Epigenetic mechanisms regulating CYP19 transcription in human breast adipose fibroblasts

Molecular and Cellular Endocrinology

Volumn 321, Issue 2, 2010, Pages 123-130

  Knower, Kevin C ^a   To, Sarah Q ^a,b   Simpson, Evan R ^a,b   Clyne, Colin D ^a,b  

^a HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aromatase; Breast adipose fibroblasts; Breast cancer; Epigenetics; Estrogen biosynthesis

Indexed keywords

AROMATASE; MESSENGER RNA; DNA (CYTOSINE 5) METHYLTRANSFERASE; DNA MODIFICATION METHYLASE SSSI;

ADIPOSE TISSUE CELL; ARTICLE; BREAST; CELL LINE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; ENZYME ACTIVITY; ENZYME REGULATION; EPIGENETICS; FIBROBLAST; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION; ADIPOSE TISSUE; BREAST TUMOR; CYTOLOGY; FEMALE; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ADIPOSE TISSUE; AROMATASE; BREAST NEOPLASMS; CELL LINE, TUMOR; CPG ISLANDS; DNA METHYLATION; DNA-CYTOSINE METHYLASES; EPIGENESIS, GENETIC; FEMALE; FIBROBLASTS; GENE EXPRESSION REGULATION; HUMANS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 77951252199     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.02.035     Document Type: Article

References (58)

1. Ackerman G.E., Smith M.E., Mendelson C.R., MacDonald P.C., Simpson E.R. Aromatization of androstenedione by human adipose tissue stromal cells in monolayer culture. J. Clin. Endocrinol. Metab. 1981, 53:412-417.
2. Agarwal V.R., Bulun S.E., Leitch M., Rohrich R., Simpson E.R. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients. J. Clin. Endocrinol. Metab. 1996, 81:3843-3849.
3. Allinen M., Beroukhim R., Cai L., Brennan C., Lahti-Domenici J., Huang H., Porter D., Hu M., Chin L., Richardson A., Schnitt S., Sellers W.R., Polyak K. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell 2004, 6:17-32.
4. Bock C., Reither S., Mikeska T., Paulsen M., Walter J., Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics 2005, 21:4067-4068.
5. Brena R.M., Huang T.H., Plass C. Toward a human epigenome. Nat. Genet. 2006, 38:1359-1360.
6. Brueggemeier R.W., Quinn A.L., Parrett M.L., Joarder F.S., Harris R.E., Robertson F.M. Correlation of aromatase and cyclooxygenase gene expression in human breast cancer specimens. Cancer Lett. 1999, 140:27-35.
7. Bulun S.E., Simpson E.R. Regulation of aromatase expression in human tissues. Breast Cancer Res. Treat. 1994, 30:19-29.
8. Bulun S.E., Simpson E.R. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. J. Clin. Endocrinol. Metab. 1994, 78:428-432.
9. Bulun S.E., Price T.M., Aitken J., Mahendroo M.S., Simpson E.R. A link between breast cancer and local estrogen biosynthesis suggested by quantification of breast adipose tissue aromatase cytochrome P450 transcripts using competitive polymerase chain reaction after reverse transcription. J. Clin. Endocrinol. Metab. 1993, 77:1622-1628.
10. Bulun S.E., Takayama K., Suzuki T., Sasano H., Yilmaz B., Sebastian S. Organization of the human aromatase p450 (CYP19) gene. Semin. Reprod. Med. 2004, 22:5-9.
11. Carlini P., Bria E., Giannarelli D., Felici A., Papaldo P., Fabi A., Ruggeri E.M., Milella M., Nuzzo C., Cecere F.L., Gelibter A., Pino M.S., Nistico C., Cuppone F., Metro G., Terzoli E., Cognetti F., Ferretti G. Aromatase inhibitors in post-menopausal metastatic breast carcinoma. Expert Opin. Investig. Drugs 2007, 16:1023-1036.
12. Chandrasekhar K., Raman R. De novo methylation of the proto-oncogene, c-fos, during development occurs step-wise and directionally in the laboratory mouse. Mol. Reprod. Dev. 1997, 48:421-432.
13. Cleland W.H., Mendelson C.R., Simpson E.R. Effects of aging and obesity on aromatase activity of human adipose cells. J. Clin. Endocrinol. Metab. 1985, 60:174-177.
14. Clyne C.D., Speed C.J., Zhou J., Simpson E.R. Liver receptor homologue-1 (LRH-1) regulates expression of aromatase in preadipocytes. J. Biol. Chem. 2002, 277:20591-20597.
15. Dannenberg L.O., Edenberg H.J. Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation. BMC Genom. 2006, 7:181.
16. Deb S., Zhou J., Amin S.A., Imir A.G., Yilmaz M.B., Lin Z., Bulun S.E. A novel role of sodium butyrate in the regulation of cancer-associated aromatase promoters I.3 and II by disrupting a transcriptional complex in breast adipose fibroblasts. J. Biol. Chem. 2006, 281:2585-2597.
17. Demura M., Bulun S.E. CpG dinucleotide methylation of the CYP19 I.3/II promoter modulates cAMP-stimulated aromatase activity. Mol. Cell. Endocrinol. 2008, 283:127-132.
18. Eckhardt F., Lewin J., Cortese R., Rakyan V.K., Attwood J., Burger M., Burton J., Cox T.V., Davies R., Down T.A., Haefliger C., Horton R., Howe K., Jackson D.K., Kunde J., Koenig C., Liddle J., Niblett D., Otto T., Pettett R., Seemann S., Thompson C., West T., Rogers J., Olek A., Berlin K., Beck S. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat. Genet. 2006, 38:1378-1385.
19. Esteller M., Herman J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol. 2002, 196:1-7.
20. Fiegl H., Millinger S., Goebel G., Muller-Holzner E., Marth C., Laird P.W., Widschwendter M. Breast cancer DNA methylation profiles in cancer cells and tumor stroma: association with HER-2/neu status in primary breast cancer. Cancer Res. 2006, 66:29-33.
21. Flotho C., Claus R., Batz C., Schneider M., Sandrock I., Ihde S., Plass C., Niemeyer C.M., Lubbert M. The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia 2009, 23:1019-1028.
22. Fujii G., Nakamura Y., Tsukamoto D., Ito M., Shiba T., Takamatsu N. CpG methylation at the USF-binding site is important for the liver-specific transcription of the chipmunk HP-27 gene. Biochem. J. 2006, 395:203-209.
23. Furbass R., Selimyan R., Vanselow J. DNA methylation and chromatin accessibility of the proximal Cyp 19 promoter region 1.5/2 correlate with expression levels in sheep placentomes. Mol. Reprod. Dev. 2008, 75:1-7.
24. Furbass R., Said H.M., Schwerin M., Vanselow J. Chromatin structure of the bovine Cyp19 promoter 1.1. DNaseI hypersensitive sites and DNA hypomethylation correlate with placental expression. Eur. J. Biochem. 2001, 268:1222-1227.
25. Harada N. Aberrant expression of aromatase in breast cancer tissues. J. Steroid Biochem. Mol. Biol. 1997, 61:175-184.
26. Harada N., Utsumi T., Takagi Y. Tissue-specific expression of the human aromatase cytochrome P-450 gene by alternative use of multiple exons 1 and promoters, and switching of tissue-specific exons 1 in carcinogenesis. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:11312-11316.
27. Hinshelwood R.A., Clark S.J. Breast cancer epigenetics: normal human mammary epithelial cells as a model system. J. Mol. Med. 2008.
28. Hu M., Yao J., Cai L., Bachman K.E., van den Brule F., Velculescu V., Polyak K. Distinct epigenetic changes in the stromal cells of breast cancers. Nat. Genet. 2005, 37:899-905.
29. Imir A.G., Lin Z., Yin P., Deb S., Yilmaz B., Cetin M., Cetin A., Bulun S.E. Aromatase expression in uterine leiomyomata is regulated primarily by proximal promoters I.3/II. J. Clin. Endocrinol. Metab. 2007, 92:1979-1982.
30. Irahara N., Miyoshi Y., Taguchi T., Tamaki Y., Noguchi S. Quantitative analysis of aromatase mRNA expression derived from various promoters (I.4, I.3, PII and I.7) and its association with expression of TNF-alpha, IL-6 and COX-2 mRNAs in human breast cancer. Int. J. Cancer 2006, 118:1915-1921.
31. Izawa M., Harada T., Taniguchi F., Ohama Y., Takenaka Y., Terakawa N. An epigenetic disorder may cause aberrant expression of aromatase gene in endometriotic stromal cells. Fertil. Steril. 2008, 89:1390-1396.
32. Jones B., Chen J. Inhibition of IFN-gamma transcription by site-specific methylation during T helper cell development. EMBO J. 2006, 25:2443-2452.
33. Jones P.A., Baylin S.B. The epigenomics of cancer. Cell 2007, 128:683-692.
34. Kijima I., Ye J., Glackin C., Chen S. CCAAT/enhancer binding protein delta up-regulates aromatase promoters I.3/II in breast cancer epithelial cells. Cancer Res. 2008, 68:4455-4464.
35. Leshin M. 5-Azacytidine and sodium butyrate induce expression of aromatase in fibroblasts from chickens carrying the henny feathering trait but not from wild-type chickens. Proc. Natl. Acad. Sci. U.S.A. 1985, 82:3005-3009.
36. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002, 18:1427-1431.
37. Mahendroo M.S., Mendelson C.R., Simpson E.R. Tissue-specific and hormonally controlled alternative promoters regulate aromatase cytochrome P450 gene expression in human adipose tissue. J. Biol. Chem. 1993, 268:19463-19470.
38. Qiu W., Hu M., Sridhar A., Opeskin K., Fox S., Shipitsin M., Trivett M., Thompson E.R., Ramakrishna M., Gorringe K.L., Polyak K., Haviv I., Campbell I.G. No evidence of clonal somatic genetic alterations in cancer-associated fibroblasts from human breast and ovarian carcinomas. Nat. Genet. 2008, 40:650-655.
39. Rink J.D., Simpson E.R., Barnard J.J., Bulun S.E. Cellular characterization of adipose tissue from various body sites of women. J. Clin. Endocrinol. Metab. 1996, 81:2443-2447.
40. Rohde C., Zhang Y., Jurkowski T.P., Stamerjohanns H., Reinhardt R., Jeltsch A. Bisulfite sequencing data presentation and compilation (BDPC) web server-a useful tool for DNA methylation analysis. Nucleic Acids Res. 2008, 36:e34.
41. Santini V., Kantarjian H.M., Issa J.P. Changes in DNA methylation in neoplasia: pathophysiology and therapeutic implications. Ann. Intern. Med. 2001, 134:573-586.
42. Schrey M.P., Patel K.V. Prostaglandin E2 production and metabolism in human breast cancer cells and breast fibroblasts. Regulation by inflammatory mediators. Br. J. Cancer 1995, 72:1412-1419.
43. Shann Y.J., Cheng C., Chiao C.H., Chen D.T., Li P.H., Hsu M.T. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res. 2008, 18:791-801.
44. Simpson E.R. Aromatase: biologic relevance of tissue-specific expression. Semin. Reprod. Med. 2004, 22:11-23.
45. Simpson E.R., Zhao Y., Agarwal V.R., Michael M.D., Bulun S.E., Hinshelwood M.M., Graham-Lorence S., Sun T., Fisher C.R., Qin K., Mendelson C.R. Aromatase expression in health and disease. Recent Prog. Horm. Res. 1997, 52:185-213. discussion 213-4.
46. Sofi M., Young M.J., Papamakarios T., Simpson E.R., Clyne C.D. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res. Treat. 2003, 79:399-407.
47. Sullivan K.E., Reddy A.B., Dietzmann K., Suriano A.R., Kocieda V.P., Stewart M., Bhatia M. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol. 2007, 27:5147-5160.
48. Tao L., Yang S., Xie M., Kramer P.M., Pereira M.A. Hypomethylation and overexpression of c-jun and c-myc protooncogenes and increased DNA methyltransferase activity in dichloroacetic and trichloroacetic acid-promoted mouse liver tumors. Cancer Lett. 2000, 158:185-193.
49. Thorsen T., Tangen M., Stoa K.F. Concentration of endogenous oestradiol as related to oestradiol receptor sites in breast tumor cytosol. Eur. J. Cancer Clin. Oncol. 1982, 18:333-337.
50. Vanselow J., Pohland R., Furbass R. Promoter-2-derived Cyp19 expression in bovine granulosa cells coincides with gene-specific DNA hypo-methylation. Mol. Cell. Endocrinol. 2005, 233:57-64.
51. Vanselow J., Selimyan R., Furbass R. DNA methylation of placenta-specific Cyp19 promoters of cattle and sheep. Exp. Clin. Endocrinol. Diabet. 2008.
52. Wilson A.S., Power B.E., Molloy P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 2007, 1775:138-162.
53. Zhao Y., Mendelson C.R., Simpson E.R. Characterization of the sequences of the human CYP19 (aromatase) gene that mediate regulation by glucocorticoids in adipose stromal cells and fetal hepatocytes. Mol. Endocrinol. 1995, 9:340-349.
54. Zhao Y., Agarwal V.R., Mendelson C.R., Simpson E.R. Estrogen biosynthesis proximal to a breast tumor is stimulated by PGE2 via cyclic AMP, leading to activation of promoter II of the CYP19 (aromatase) gene. Endocrinology 1996, 137:5739-5742.
55. Zhao Y., Nichols J.E., Bulun S.E., Mendelson C.R., Simpson E.R. Aromatase P450 gene expression in human adipose tissue. Role of a Jak/STAT pathway in regulation of the adipose-specific promoter. J. Biol. Chem. 1995, 270:16449-16457.
56. Zhao Y., Nichols J.E., Valdez R., Mendelson C.R., Simpson E.R. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. Mol. Endocrinol. 1996, 10:1350-1357.
57. Zhou D., Zhou C., Chen S. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells. J. Steroid Biochem. Mol. Biol. 1997, 61:273-280.
58. Zilberman D., Henikoff S. Genome-wide analysis of DNA methylation patterns. Development 2007, 134:3959-3965.